Assessing the usefulness of the francine needle in EBUS-TBNA
Phase 2
Recruiting
- Conditions
- ung cancerlung cancer,D008175
- Registration Number
- JPRN-jRCT1032220388
- Lead Sponsor
- Ikari Jun
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 12
Inclusion Criteria
1)Patients with suspected primary lung cancer
2)Patients who are scheduled for endobronchial ultrasound-guided transbronchial needle aspiration or biopsy
3)Patients who are 20 years of age or older
4)Patients who are provided written informed consent
Exclusion Criteria
1)Patients who have a history of treatment for lung cancer
2)Patients for whom bronchoscopy is contraindicated
3)Patients who are pregnant, within 28 days postpartum, or lactating
4)Patients who are judged by the investigator to be unsuitable for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tissue area of each lymph node sample
- Secondary Outcome Measures
Name Time Method Tumor percentage of each lymph node<br>Rate of blood contamination in each lymph node<br>Diagnostic concordance between Francine and Lancet needles<br>Adverse events<br>Success rate for biomarker test for each lymph node